Literature DB >> 29756397

Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer.

Kelly C Landeen1, William C Spanos2, Laurie Gromer2.   

Abstract

BACKGROUND: Topical superoxide dismutase (SOD) has been shown to decrease postradiation fibrosis in some cancers but has not demonstrated an effect in patients with head and neck cancer. The purpose of this study was to determine if topical SOD is an effective treatment for postradiation neck fibrosis.
METHODS: This was a randomized prospective blinded clinical study of topical SOD versus placebo for the treatment of neck fibrosis. Measures of fibrosis grade and quality of life were obtained at baseline and after 3 months of treatment.
RESULTS: Improvement in fibrosis score was comparable between the 2 study arms at 3 months.
CONCLUSION: Both study groups showed improvement but the differences between groups was not statistically significant. Topical SOD likely has limited benefit for posttreatment neck fibrosis but this study confirms other published evidence of benefit from active physical therapy of posttreatment fibrosis in patients with head and neck cancer.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  fibrosis; head and neck cancer; quality of life; radiation; superoxide dismutase

Mesh:

Substances:

Year:  2018        PMID: 29756397     DOI: 10.1002/hed.25119

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Interventions for Radiation-Induced Fibrosis in Patients With Breast Cancer: Systematic Review and Meta-analyses.

Authors:  Regiane Mazzarioli Pereira Nogueira; Flávia Maria Ribeiro Vital; Daniel Galera Bernabé; Marcos Brasilino de Carvalho
Journal:  Adv Radiat Oncol       Date:  2022-02-05

2.  Screening of differentially methylated genes in breast cancer and risk model construction based on TCGA database.

Authors:  Liang Feng; Feng Jin
Journal:  Oncol Lett       Date:  2018-09-19       Impact factor: 2.967

3.  Increased risk of cerebrovascular mortality in head and neck cancer survivors aged ≥ 65 years treated with definitive radiotherapy: a population-based cohort study.

Authors:  Qing-Song He; Zhen-Ping Wang; Zhao-Jun Li; Ping Zhou; Chen-Lu Lian; San-Gang Wu; Si-Fang Chen
Journal:  Radiat Oncol       Date:  2021-09-20       Impact factor: 3.481

Review 4.  Radiation-Induced Fibrosis in Patients with Head and Neck Cancer: A Review of Pathogenesis and Clinical Outcomes.

Authors:  Paul Ramia; Larry Bodgi; Dima Mahmoud; Mohammad A Mohammad; Bassem Youssef; Neil Kopek; Humaid Al-Shamsi; Mona Dagher; Ibrahim Abu-Gheida
Journal:  Clin Med Insights Oncol       Date:  2022-01-30

Review 5.  Superoxide Dismutase Administration: A Review of Proposed Human Uses.

Authors:  Arianna Carolina Rosa; Daniele Corsi; Niccolò Cavi; Natascia Bruni; Franco Dosio
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.